(2S)-2-Bromopropanoic acid | CAS:32644-15-8

We serve (2S)-2-Bromopropanoic acid CAS:32644-15-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(2S)-2-Bromopropanoic acid

Synonyms:
(S)-(-)-2-BroMopropionic Acid
sGPhCQbILuSRX@
L-2-Bromopropionic Acid
 
Molecular Formula: C3H5BrO2
Molecular Weight: 152.97500
 
 
Appearance and properties: colorless liquid
Density: 1.696 g/mL at 20ºC(lit.)
Boiling point: 78ºC4 mm Hg(lit.)
Melting point: -35ºC(lit.)
Flash point: 100ºC
Refractive index: n20/D 1.475
 
Storage conditions: 2-8ºC
Applications: Detection of enantiomeric structure of carboxylic acid in nuclear magnetic resonance.

 

Items of Analysis Standard of Analysis Test Results
Appearance Colorless to pale yellow oily liquid Pale yellow oily liquid
Specific rotation -29.0o ~ -35.0o -33.83o
Purity (GC) ≥98.0% 98.13%
Conclusion Conforms to Factory Standard
 

 



Contact us for information like (2S)-2-Bromopropanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-2-Bromopropionic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-2-Bromopropanoic acid Use and application,(S)-(-)-2-BroMopropionic Acid technical grade,usp/ep/jp grade.


Related News: Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.Benzenesulfonyl fluoride, 5-fluoro-2-methyl- manufacturer The StartScore model was developed by the company’s in-house supply chain experts based on actual performance data.7-Allyl-9-methoxy-3-oxa-7-azabicyclo(4.3.0)non-9-ene-2,8-dione supplier The StartScore model was developed by the company’s in-house supply chain experts based on actual performance data.rel-((3R,4S)-4-(3,4-dichlorophenyl)-1-methylpiperidin-3-yl)methanol vendor With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.